Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Dec 14, 2014; 20(46): 17407-17415
Published online Dec 14, 2014. doi: 10.3748/wjg.v20.i46.17407
Published online Dec 14, 2014. doi: 10.3748/wjg.v20.i46.17407
Gr. (n) | Bils, mg/dL | ASTs, IU/L | ALTs, IU/L | Albumins, mg/dL | Ammons,μmol/L |
1 (8) | |||||
Sham | 0.40 ± 0.26 | 252.50 ± 149.8 | 56.2 ± 9.9 | 2.9 ± 0.1 | 52.8 ± 38.1 |
2 (8) | |||||
Ga1N | 3.43 ± 1.35 | 1624.12 ± 692.92 | 2098.6 ± 886.1 | 2.6 ± 0.1 | 275.7 ± 73.7 |
8 (8) | |||||
Sham L-ARG | 0.38 ± 0.21 | 126.37 ± 33.95 | 53.75 ± 7.37 | 2.67 ± 0.09 | 50.7 ± 46.2 |
9 (8) | |||||
L-ARG/Ga1N | 2.96 ± 0.67 | 1484.87 ± 328.75 | 1546.37 ± 349.75 | 2.75 ± 0.1 | 199.12 ± 42.8 |
10 (8) | |||||
2xL-ARG/Ga1N | 2.92 ± 0.89 | 1611.75 ± 334.58 | 1603.75 ± 364.47 | 2.73 ± 0.06 | 193.87 ± 50.49 |
11 (8) | |||||
Ga1N/L-ARG | 2.86 ± 0.94 | 1491.87 ± 421.49 | 1486.25 ± 450.83 | 2.42 ± 0.21 | 195.25 ± 41.69 |
12 (8) | |||||
Ga1N/2xL-ARG | 2.96 ± 0.98 | 1446.25 ± 219.35 | 1435.62 ± 281.33 | 2.72 ± 0.11 | 180.5 ± 45.80 |
gr. 2 vs gr. 1 | P < 0.004 | P < 0.0001 | P < 0.001 | P < 0.001 | P < 0.005 |
gr. 8 vs gr. 1 | P < 0.11 | P < 0.047 | P < 0.60 | P < 0.0007 | P < 0.340 |
gr. 9 vs gr. 2 | P < 0.41 | P < 0.63 | P < 0.14 | P < 0.09 | P < 0.032 |
gr. 10 vs gr. 2 | P < 0.41 | P < 0.96 | P < 0.19 | P < 0.10 | P < 0.029 |
gr. 11 vs gr. 2 | P < 0.37 | P < 0.67 | P < 0.12 | P < 0.06 | P < 0.024 |
gr. 12 vs gr. 2 | P < 0.46 | P < 0.52 | P < 0.08 | P < 0.20 | P < 0.011 |
- Citation: Saracyn M, Brytan M, Zdanowski R, Ząbkowski T, Dyrla P, Patera J, Wojtuń S, Kozłowski W, Wańkowicz Z. Hepatoprotective effect of nitric oxide in experimental model of acute hepatic failure. World J Gastroenterol 2014; 20(46): 17407-17415
- URL: https://www.wjgnet.com/1007-9327/full/v20/i46/17407.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i46.17407